Holter Versus Zio Patch Electrocardiographic Monitoring in Children
- Conditions
- Arrhythmias, CardiacHeart Block
- Interventions
- Device: Holter MonitorDevice: Zio Patch
- Registration Number
- NCT03309956
- Lead Sponsor
- Columbia University
- Brief Summary
This prospective study aims to compare the diagnostic yield, or ability to detect an arrhythmia, of the traditional Holter monitor versus the novel Zio patch monitor in pediatric patients referred for ambulatory electrocardiographic (ECG) monitoring. Children will wear both devices simultaneously for 48 hours and the incidence of clinically significant arrhythmias will be compared.
- Detailed Description
Patients under age 22 years at Children's Hospital of New York (CHONY) who are referred for ambulatory ECG monitoring will be consented and enrolled prospectively to have the Holter monitor and the Zio patch placed simultaneously in the pediatric cardiology clinic. Patients will be instructed to wear both devices for 48 hours. Demographic data will be collected, including date of birth, age, gender, weight, height, chest circumference, body surface area, indication for ambulatory ECG monitoring, prior congenital heart disease, prior cardiac surgery, and prior Holter or Zio patch use. A patient satisfaction survey will be given to the patient and parent/guardian after completion of the study to compare the comfort, interference with daily activities, adverse events (such as skin irritation or if either device fell off), and preference for each device. Holter monitors will be returned to the clinic along with the patient satisfaction survey, and the Zio patch will be mailed back to manufacturer headquarters and the report will be returned to the investigators.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 247
- Any patient under age 22 years who has been referred for ambulatory ECG monitoring at Children's Hospital of New York.
- Any known skin allergy or sensitivity to adhesive material.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Holter Monitor and Zio Patch Holter Monitor All subjects will wear the Holter monitor and Zio patch for a total of 48 hours. Holter Monitor and Zio Patch Zio Patch All subjects will wear the Holter monitor and Zio patch for a total of 48 hours.
- Primary Outcome Measures
Name Time Method Number of Participants With Difference in Detection of Clinically Significant Arrhythmias for the Zio Versus the Holter 48 hours The diagnostic yield, or the ability to detect an arrhythmia, will be measured for the Holter monitor and the Zio patch monitor for each patient. The diagnostic yield for each arrhythmia subtype will be determined for each device across all patients and compared in paired statistical analysis (McNemar's test).
- Secondary Outcome Measures
Name Time Method Prevalence of Artifact Detected 48 hours The aggregate percent analyzable data of the Holter monitor compared to the Zio Patch across all patients will be calculated using descriptive statistics.
Trial Locations
- Locations (1)
Columbia University Medical Center
🇺🇸New York, New York, United States